Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- End Stage Renal Disease
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02490904
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Frédéric JAISSER, MD CHRU de Nancy Study Chair: Sophie GIRERD, MD CHRU de NANCY Study Chair: Nicolas GIRERD, MD, PhD CHRU de Nancy Study Chair: Luc FRIMAT, MD, PhD CHRU de Nancy Study Chair: Patrick ROSSIGNOL, MD, PhD CHRU de Nancy
Get Well Soon